The surfactant system of the adult lung: physiology and clinical perspectives
暂无分享,去创建一个
W. Bartsch | H. Fabel | H. Hamm | H. Fabel | W. Bartsch | H. Hamm
[1] S. Schürch,et al. Effects of hydrogen sulfide exposure on surface properties of lung surfactant. , 1991, Journal of applied physiology.
[2] R. E. Pattle. The relation between surface tension and area in the alveolar lining film , 1977, The Journal of physiology.
[3] R. Kriz,et al. Isolation and characterization of cDNA clones for the 35-kDa pulmonary surfactant-associated protein. , 1986, The Journal of biological chemistry.
[4] S. Goldman,et al. Decreased mortality rate among small premature infants treated at birth with a single dose of synthetic surfactant: a multicenter controlled trial. American Exosurf Pediatric Study Group 1. , 1991, The Journal of pediatrics.
[5] J. Whitsett,et al. Enhancement of biophysical activity of lung surfactant extracts and phospholipid-apoprotein mixtures by surfactant protein A. , 1990, Chemistry and physics of lipids.
[6] F. Possmayer,et al. Role of bovine pulmonary surfactant-associated proteins in the surface-active property of phospholipid mixtures. , 1990, Biochimica et biophysica acta.
[7] R. Mason. Surfactant in adult respiratory distress syndrome. , 1987, European journal of respiratory diseases. Supplement.
[8] J. Wispé,et al. Effects of Pulmonary Oxygen Injury on Airway Content of Surfactant-Associated Protein A , 1988, Pediatric Research.
[9] E. S. Wright. Effects of short-term exposure to diesel exhaust on lung cell proliferation and phospholipid metabolism. , 1986, Experimental lung research.
[10] F. Possmayer. The role of surfactant-associated proteins. , 1990, The American review of respiratory disease.
[11] J. Goerke,et al. Pulmonary surface film stability and composition. , 1979, Journal of applied physiology: respiratory, environmental and exercise physiology.
[12] J. J. Batenburg,et al. Aspects of metabolism and storage of pulmonary surfactant: experiments with isolated type II pneumocytes and lamellar bodies. , 1987, European journal of respiratory diseases. Supplement.
[13] J. Engel,et al. Macromolecular organization of natural and recombinant lung surfactant protein SP 28-36. Structural homology with the complement factor C1q. , 1988, Journal of molecular biology.
[14] G. Soula,et al. Biochemical modifications of pulmonary surfactant after bromhexine derivate injection. , 1979, Respiration; international review of thoracic diseases.
[15] Y. Kuroki,et al. Surfactant protein D (SP-D) counteracts the inhibitory effect of surfactant protein A (SP-A) on phospholipid secretion by alveolar type II cells. Interaction of native SP-D with SP-A. , 1991, The Biochemical journal.
[16] W. Seeger,et al. Alteration of surfactant function due to protein leakage: special interaction with fibrin monomer. , 1985, Journal of applied physiology.
[17] T. Wilson. Relations among recoil pressure, surface area, and surface tension in the lung. , 1981, Journal of applied physiology: respiratory, environmental and exercise physiology.
[18] M. Williams,et al. Changes in lipid structure produced by surfactant proteins SP-A, SP-B, and SP-C. , 1991, American journal of respiratory cell and molecular biology.
[19] S. Matalon,et al. Role of Pulmonary Surfactant in the Development and Treatment of Adult Respiratory Distress Syndrome , 1989, Anesthesia and analgesia.
[20] H. Takahashi,et al. Alterations of acidic phospholipids in bronchoalveolar lavage fluids of patients with pulmonary alveolar proteinosis. , 1989, Clinica chimica acta; international journal of clinical chemistry.
[21] B. Lachmann. Animal models and clinical pilot studies of surfactant replacement in adult respiratory distress syndrome. , 1989, The European respiratory journal. Supplement.
[22] J A Clements,et al. Metabolism and turnover of lung surfactant. , 1987, The American review of respiratory disease.
[23] W. Longmore,et al. Surfactant cholesterol metabolism of the isolated perfused rat lung. , 1979, Biochimica et biophysica acta.
[24] J. Wright,et al. Human pulmonary surfactant protein (SP-A), a protein structurally homologous to C1q, can enhance FcR- and CR1-mediated phagocytosis. , 1989, The Journal of biological chemistry.
[25] G. Alink,et al. Effects of ozone on phospholipid synthesis by alveolar type II cells isolated from adult rat lung. , 1985, Experimental lung research.
[26] J. E. Bleasdale,et al. Altered lipid synthesis in type II pneumonocytes exposed to lung surfactant. , 1986, The Biochemical journal.
[27] S. Thiel,et al. Human leukocyte C1q receptor binds other soluble proteins with collagen domains , 1990, The Journal of experimental medicine.
[28] C. R. Barrett,et al. Functional abnormalities of lung surfactant in experimental acute alveolar injury in the dog. , 1987, The American review of respiratory disease.
[29] P. R. Miles,et al. Degradation of pulmonary surfactant disaturated phosphatidylcholines by alveolar macrophages. , 1988, Journal of applied physiology.
[30] J. Wright,et al. Pulmonary surfactant and its components inhibit secretion of phosphatidylcholine from cultured rat alveolar type II cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[31] H. Plattner,et al. Specific interaction of lung surfactant protein A (SP-A) with rat alveolar macrophages. , 1991, Experimental cell research.
[32] J. Murray,et al. Effects of aerosolized artificial surfactant on repeated oleic acid injury in sheep. , 1990, The American review of respiratory disease.
[33] C. Cochrane,et al. Pulmonary surfactant protein B (SP-B): structure-function relationships. , 1991, Science.
[34] A. Anzueto,et al. O2- and pneumonia-induced lung injury. II. Properties of pulmonary surfactant. , 1989, Journal of applied physiology.
[35] J. Verhoef,et al. Surfactant protein A is opsonin in phagocytosis of herpes simplex virus type 1 by rat alveolar macrophages. , 1991, The American journal of physiology.
[36] R. Rose,et al. Increased recovery of surfactant protein A in AIDS-related pneumonia. , 1991, The American review of respiratory disease.
[37] L. Gluck,et al. Absence of Phosphatidylglycerol (PG) in Respiratory Distress Syndrome in the Newborn , 1977, Pediatric Research.
[38] S. Yasui,et al. Changes of lung surfactant and pressure-volume curve in bleomycin-induced pulmonary fibrosis. , 1991, Journal of applied physiology.
[39] P. Richman,et al. Immunomodulation by pulmonary surfactant. , 1988, The Journal of laboratory and clinical medicine.
[40] D. Voelker,et al. Idiopathic pulmonary fibrosis. Abnormalities in the bronchoalveolar lavage content of surfactant protein A. , 1991, The American review of respiratory disease.
[41] A. Persson,et al. Surfactant protein D is a divalent cation-dependent carbohydrate-binding protein. , 1990, The Journal of biological chemistry.
[42] I. Gribetz,et al. Pulmonary surface tension and alveolar stability. , 1961, Journal of applied physiology.
[43] J. Shannon,et al. In vivo regulation of surfactant proteins by glucocorticoids. , 1991, American journal of respiratory cell and molecular biology.
[44] A. Waring,et al. Structure-function relationships of bovine pulmonary surfactant proteins: SP-B and SP-C. , 1990, Biochimica et biophysica acta.
[45] D. Hendrick,et al. Fluid dynamics during bronchoalveolar lavage. , 1988, The American review of respiratory disease.
[46] J. Coonrod. Rôle of surfactant free fatty acids in antimicrobial defenses. , 1987, European journal of respiratory diseases. Supplement.
[47] A. Lykke,et al. Injury to type-2 pneumocytes in rats exposed to cigarette smoke. , 1981, Environmental research.
[48] T M Dwyer,et al. Types of interaction of amphiphilic drugs with phospholipid vesicles. , 1988, The Journal of pharmacology and experimental therapeutics.
[49] J. Luce,et al. Pharmacologic treatment of the adult respiratory distress syndrome. , 1990, Clinics in chest medicine.
[50] F. Snyder,et al. Sequential changes in phospholipid composition and synthesis in lungs exposed to nitrogen dioxide. , 2015, The American review of respiratory disease.
[51] Jacob N. Filkelstein. Physiologic and toxicologic responses of alveolar type II cells. , 1990 .
[52] T. Welte,et al. Mesalazine alveolitis , 1991, The Lancet.
[53] O. Kalaycıoğlu,et al. Increased surfactant protein A content in human alveolar macrophages in hypersensitivity pneumonitis. , 1992, Acta cytologica.
[54] Coonrod Jd. Rôle of surfactant free fatty acids in antimicrobial defenses. , 1987 .
[55] N. Morton. Exogenous surfactant treatment for the adult respiratory distress syndrome? A historical perspective. , 1990, Thorax.
[56] P. Ballard,et al. Hormonal regulation of pulmonary surfactant. , 1989, Endocrine reviews.
[57] P. Vadas,et al. Acute lung injury induced by phospholipase A2. Structural and functional changes. , 1991, The American review of respiratory disease.
[58] J. Gitlin,et al. Randomized controlled trial of exogenous surfactant for the treatment of hyaline membrane disease. , 1987, Pediatrics.
[59] Schwartz Lw,et al. Alveolar macrophage migration. Influence of lung lining material and acute lung insult. , 1979 .
[60] J. Floros. Sixty years of surfactant research. , 1990, The American journal of physiology.
[61] J. Harwood. Lung surfactant. , 1987, Progress in lipid research.
[62] R. Matthay,et al. Drug-induced pulmonary disease. , 2015, Disease-a-month : DM.
[63] B. Gladen,et al. Effects of silica on the composition of the pulmonary extracellular lining. , 1986, Toxicology and applied pharmacology.
[64] M. Hallman,et al. Surfactant abnormality after endotoxin-induced lung injury in guinea-pigs. , 1987, European journal of respiratory diseases.
[65] S. Matalon,et al. Characterization of antioxidant activities of pulmonary surfactant mixtures. , 1990, Biochimica et biophysica acta.
[66] L. Hudson,et al. Causes of Mortality in Patients with the Adult Respiratory Distress Syndrome , 1985, The American review of respiratory disease.
[67] L. V. van Golde. Metabolism of phospholipids in the lung. , 1976, The American review of respiratory disease.
[68] D. Nelson,et al. Phospholipids as dynamic participants in biological processes. , 1984, Journal of lipid research.
[69] J. Finkelstein,et al. Surface property changes from interactions of albumin with natural lung surfactant and extracted lung lipids. , 1985, Chemistry and physics of lipids.
[70] S. Matalon,et al. Sublethal hyperoxic injury to the alveolar epithelium and the pulmonary surfactant system. , 1988, Experimental lung research.
[71] S. Nosaka,et al. Surfactant for adults with respiratory failure , 1990, The Lancet.
[72] R. Baughman,et al. Enhancement of macrophage and monocyte cytotoxicity by the surface active material of lung lining fluid. , 1987, The Journal of laboratory and clinical medicine.
[73] M. V. van Greevenbroek,et al. Structural and functional changes of surfactant protein A induced by ozone. , 1991, The American journal of physiology.
[74] A. Slomiany,et al. Isolation and characterization of a sulfated glyceroglucolipid from alveolar lavage of rabbit. , 1979, European journal of biochemistry.
[75] R. Albert,et al. Surfactant replacement improves lung recoil in rabbit lungs after acid aspiration. , 1990, The American review of respiratory disease.
[76] F. Possmayer. A proposed nomenclature for pulmonary surfactant-associated proteins. , 1988, The American review of respiratory disease.
[77] Gordon R Bernard,et al. Acute respiratory distress syndrome: a historical perspective. , 2005, American journal of respiratory and critical care medicine.
[78] H. Halliday. Clinical experience with exogenous natural surfactant. , 1989, Developmental pharmacology and therapeutics.
[79] W. Seeger,et al. Altered pulmonary surfactant in uncomplicated and septicemia-complicated courses of acute respiratory failure. , 1990, The Journal of trauma.
[80] J A CLEMENTS,et al. Surface Tension of Lung Extracts , 1957, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[81] W. Klepetko,et al. Pulmonary surfactant in bronchoalveolar lavage after canine lung transplantation: effect of L-carnitine application. , 1990, The Journal of thoracic and cardiovascular surgery.
[82] R. Auten,et al. Surfactant apoprotein A (SP-A) is synthesized in airway cells. , 1990, American journal of respiratory cell and molecular biology.
[83] William W. Cook,et al. Enhancement of bactericidal capacity of alveolar macrophages by human alveolar lining material. , 1976, The Journal of clinical investigation.
[84] A. Jobe,et al. Surfactant for the treatment of respiratory distress syndrome. , 1987, The American review of respiratory disease.
[85] M. Montgomery,et al. Ozone stress initiates acute perturbations of secreted surfactant membranes. , 1991, The American journal of pathology.
[86] S. O’Neill,et al. Rat lung lavage surfactant enhances bacterial phagocytosis and intracellular killing by alveolar macrophages. , 1984, The American review of respiratory disease.
[87] W. Seeger,et al. Surfactant abnormalities in patients with respiratory failure after multiple trauma. , 1989, The American review of respiratory disease.
[88] J. Dubbeldam,et al. The proximal border of the human respiratory unit, as shown by scanning and transmission electron microscopy and light microscopical cytochemistry , 1991, The Anatomical record.
[89] V. Ferrans,et al. Structure of alveolar epithelial cells in patients with fibrotic lung disorders. , 1982, Laboratory investigation; a journal of technical methods and pathology.
[90] Y. Kuroki,et al. Surface and tissue forces, surfactant protein A, and the phospholipid components of pulmonary surfactant in bleomycin-induced pulmonary fibrosis in the rat. , 1990, The American review of respiratory disease.
[91] J. Clements. Smoking and pulmonary surfactant. , 1972, The New England journal of medicine.
[92] D. Hughes,et al. Immunoregulatory properties of pulmonary surfactant: effect of lung lining fluid on proliferation of human blood lymphocytes. , 1988, Thorax.
[93] J. Johansson,et al. Surfactant protein B: disulfide bridges, structural properties, and kringle similarities. , 1991, Biochemistry.
[94] J. Zahm,et al. Rheological and transport properties of airway secretions in cystic fibrosis‐relationships with the degree of infection and severity of the disease , 1985, European journal of clinical investigation.
[95] D. Vidyasagar,et al. A multicenter randomized, placebo‐controlled trial of surfactant therapy for respiratory distress syndrome , 1989, The New England journal of medicine.
[96] M. Fujimura,et al. Surfactant Replacement Therapy With a Single Postventilatory Dose of a Reconstituted Bovine Surfactant in Preterm Neonates With Respiratory Distress Syndrome: Final Analysis of a Multicenter, Double-blind, Randomized Trial and Comparison With Similar Trials , 1990, Pediatrics.
[97] E. Arner,et al. Long-term nitrogen dioxide exposure: effects on lung lipids and mechanical properties. , 1973, Archives of environmental health.
[98] J. Verhoef,et al. Pulmonary surfactant protein A enhances the host-defense mechanism of rat alveolar macrophages. , 1990, American journal of respiratory cell and molecular biology.
[99] J. Whitsett,et al. Surfactant protein SP-B induces ordering at the surface of model membrane bilayers. , 1990, Biochemistry.
[100] R. Wolfe,et al. Bacteremia-induced suppression of alveolar surfactant production. , 1989, The Journal of surgical research.
[101] D. Stokes,et al. Surfactant phospholipids and lavage phospholipase A2 in experimental Pneumocystis carinii pneumonia. , 1986, The American review of respiratory disease.
[102] J N Finkelstein. Physiologic and toxicologic responses of alveolar type II cells. , 1990, Toxicology.
[103] Van Golde Lm. Metabolism of phospholipids in the lung. , 1976 .
[104] N. Hooper,et al. Function and regulation of expression of pulmonary surfactant-associated proteins. , 1991, The Biochemical journal.
[105] Disse Bg. The pharmacology of ambroxol--review and new results , 1987 .
[106] M. Wilsher,et al. Immunosuppression by pulmonary surfactant: mechanisms of action. , 1990, Thorax.
[107] T. Voss,et al. Structural comparison of recombinant pulmonary surfactant protein SP-A derived from two human coding sequences: implications for the chain composition of natural human SP-A. , 1991, American journal of respiratory cell and molecular biology.
[108] M. Avery,et al. Surface properties in relation to atelectasis and hyaline membrane disease. , 1959, A.M.A. journal of diseases of children.
[109] R. Notter,et al. Effects of hemoglobin and cell membrane lipids on pulmonary surfactant activity. , 1987, Journal of applied physiology.
[110] A. Jobe,et al. Clearance of surfactant phosphatidylcholine via the upper airways in rabbits. , 1988, Journal of applied physiology.
[111] G. S. Davis,et al. Biochemical analyses of bronchoalveolar lavage fluids of healthy human volunteer smokers and nonsmokers. , 2015, The American review of respiratory disease.
[112] H. Reynolds. Immunologic system in the respiratory tract. , 1991, Physiological reviews.
[113] R. Baughman,et al. Lung derived surface active material (SAM) inhibits natural killer cell tumor cytotoxicity. , 1989, Journal of clinical & laboratory immunology.
[114] P. Richman,et al. The adult respiratory distress syndrome: first trials with surfactant replacement. , 1989, The European respiratory journal. Supplement.
[115] R. Cotton,et al. A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group. , 1991 .
[116] T. King,et al. Idiopathic pulmonary fibrosis. Abnormalities in bronchoalveolar lavage fluid phospholipids. , 1988, The American review of respiratory disease.
[117] K. Mori,et al. Changes of alveolar stability and phospholipids in pulmonary surfactant in acute pancreatitis , 1983, The Japanese journal of surgery.
[118] R. J. King. The surfactant system of the lung. , 1974, Federation proceedings.
[119] P. Holt. Down-regulation of immune responses in the lower respiratory tract: the role of alveolar macrophages. , 1986, Clinical and experimental immunology.
[120] H. Reynolds,et al. Limitations of using urea to quantify epithelial lining fluid recovered by bronchoalveolar lavage. , 2015, The American review of respiratory disease.
[121] A. Persson,et al. Purification and biochemical characterization of CP4 (SP-D), a collagenous surfactant-associated protein. , 1989, Biochemistry.
[122] R. Baughman,et al. Decreased phosphatidylcholine in the lung fluid of patients with sarcoidosis , 1985, Lipids.
[123] J. Wright. Clearance and recycling of pulmonary surfactant. , 1990, The American journal of physiology.
[124] J. Whitsett,et al. Binding and uptake of pulmonary surfactant protein (SP-A) by pulmonary type II epithelial cells. , 1989, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[125] K. v. Neergaard,et al. Neue Auffassungen über einen Grundbegriff der Atemmechanik , 1929 .
[126] R. Thrall,et al. Correlation of changes in pulmonary surfactant phospholipids with compliance in bleomycin-induced pulmonary fibrosis in the rat. , 1987, The American review of respiratory disease.
[127] J. Wright,et al. Surfactant apoprotein Mr = 26,000-36,000 enhances uptake of liposomes by type II cells. , 1987, The Journal of biological chemistry.
[128] D. Voelker,et al. Alveolar type II cells, surfactant protein A (SP-A), and the phospholipid components of surfactant in acute silicosis in the rat. , 1989, The American review of respiratory disease.
[129] G. Hook,et al. Dissolution and reassembly of tubular myelin-like multilamellated structures from the lungs of patients with pulmonary alveolar proteinosis. , 1986, Laboratory investigation; a journal of technical methods and pathology.
[130] H. Sasaki,et al. Surfactant apoprotein-A concentration in sputum for diagnosis of pulmonary alveolar proteinosis , 1991, The Lancet.
[131] J. Schilling,et al. Isolation and characterization of the human pulmonary surfactant apoprotein gene , 1985, Nature.
[132] G. Hook,et al. Hypertrophy and hyperplasia of alveolar type II cells in response to silica and other pulmonary toxicants. , 1990, Environmental health perspectives.
[133] J. Whitsett,et al. Glycosylation and secretion of surfactant-associated glycoprotein A. , 1985, The Journal of biological chemistry.
[134] A. Verkleij,et al. Surfactant protein A is localized at the corners of the pulmonary tubular myelin lattice. , 1991, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[135] M. Oulton,et al. Effects of smoke inhalation on surfactant phospholipids and phospholipase A2 activity in the mouse lung. , 1991, The American journal of pathology.
[136] A. Jobe,et al. Clearance of surfactant phosphatidylcholine from adult rabbit lungs. , 1988, Journal of applied physiology.
[137] J. Floros,et al. Localization of surfactant protein synthesis in human lung by in situ hybridization. , 1988, The American review of respiratory disease.
[138] J. Coonrod. Human alveolar lining material and antibacterial defenses. , 2015, The American review of respiratory disease.
[139] L. Gluck,et al. Analysis of labeling and clearance of lung surfactant phospholipids in rabbit. Evidence of bidirectional surfactant flux between lamellar bodies and alveolar lavage. , 1981, The Journal of clinical investigation.
[140] B. Hills. The role of lung surfactant. , 1990, British journal of anaesthesia.
[141] R. Hamman,et al. Adult respiratory distress syndrome. Prognosis after onset. , 1985, The American review of respiratory disease.
[142] E. Fasske. Pathogenesis of pulmonary fibrosis induced by chrysotile asbestos , 2004, Virchows Archiv A.
[143] P. Morrow,et al. Toxicological data on NOx: an overview. , 1984, Journal of toxicology and environmental health.
[144] K. Brogden,et al. Biophysical alteration of lung surfactant by extracts of cotton dust. , 1991, British journal of industrial medicine.
[145] D. Hughes,et al. Changes in phosphatidylglycerol in bronchoalveolar lavage fluids from patients with cryptogenic fibrosing alveolitis. , 1989, Chest.
[146] S. Hawgood. Pulmonary surfactant apoproteins: a review of protein and genomic structure. , 1989, The American journal of physiology.
[147] R. G. Sitrin,et al. The effect of pulmonary surface-active material on the generation and expression of murine B- and T-lymphocyte effector functions in vitro. , 1985, Experimental lung research.
[148] K. C. Kim,et al. Secretions from primary hamster tracheal surface epithelial cells in culture: mucin-like glycoproteins, proteoglycans, and lipids. , 1989, Experimental lung research.
[149] Y. Kuroki,et al. Characterization of pulmonary surfactant protein D: its copurification with lipids. , 1991, Biochimica et biophysica acta.
[150] B. Robertson,et al. Inactivation of Exogenous Surfactant by Pulmonary Edema Fluid , 1991, Pediatric Research.
[151] A. Persson,et al. Surfactant protein D. Increased accumulation in silica-induced pulmonary lipoproteinosis. , 1991, The American journal of pathology.
[152] R. Matthay,et al. Drug-induced pulmonary disease. Part 2: Noncytotoxic drugs. , 1986, The American review of respiratory disease.
[153] T. Higenbottam. Lung lipids and disease. , 1989, Respiration; international review of thoracic diseases.
[154] R. E. Pattle,et al. Properties, Function and Origin of the Alveolar Lining Layer , 1955, Nature.
[155] R. Baughman,et al. Changes in fatty acids in phospholipids of the bronchoalveolar fluid in bacterial pneumonia and in adult respiratory distress syndrome. , 1984, Clinical chemistry.
[156] S. Sekulic. [Pulmonary surfactant]. , 1974, Plucne bolesti i tuberkuloza.
[157] A. Menkis,et al. Surfactant analysis and replacement therapy: a future tool of the lung transplant surgeon? , 1991, The Annals of thoracic surgery.
[158] M. Bendayan,et al. Lung surfactant-associated proteins and type IV collagen share common epitopes. An immunocytochemical demonstration. , 1989, The American review of respiratory disease.
[159] T. N. Finley,et al. Low yield of pulmonary surfactant in cigarette smokers. , 1972, The New England journal of medicine.
[160] J. Whitsett,et al. Identification of surfactant proteolipid SP-B in human surfactant and fetal lung. , 1988, Journal of applied physiology.
[161] G. Enhorning. Surfactant replacement in adult respiratory distress syndrome. , 1989, The American review of respiratory disease.
[162] A. Fisher,et al. Regulation of lung surfactant secretion. , 1990, The American journal of physiology.
[163] K. A. Strom,et al. Pulmonary phospholipidosis in rats respiring air containing diesel particulates. , 1987, Environmental research.
[164] R. Spragg,et al. Evidence of lung surfactant abnormality in respiratory failure. Study of bronchoalveolar lavage phospholipids, surface activity, phospholipase activity, and plasma myoinositol. , 1982, The Journal of clinical investigation.
[165] R. Barrow,et al. Surface tension induced by dipalmitoyl lecithin in vitro under physiological conditions , 1979, The Journal of physiology.
[166] E. Rich. Pulmonary surfactant as a physiologic immunosuppressive agent. , 1990, The Journal of laboratory and clinical medicine.
[167] R. Vincent,et al. Toxicity of inhaled cadmium chloride: early responses of the antioxidant and surfactant systems in rat lungs. , 1988, Journal of toxicology and environmental health.
[168] P. Ballard,et al. Glucocorticoids both stimulate and inhibit production of pulmonary surfactant protein A in fetal human lung. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[169] P. Wozniak,et al. Immunologic consequences of exogenous surfactant administration. , 1988, Seminars in perinatology.
[170] G. Enhorning,et al. Artificial pulmonary surfactant inhibited by proteins. , 1987, Journal of applied physiology.
[171] S. Matalon,et al. Type II pneumocyte changes during hyperoxic lung injury and recovery. , 1988, Journal of applied physiology.
[172] J. Clements,et al. Isolation of apoproteins from canine surface active material. , 1973, The American journal of physiology.
[173] R. Soll,et al. Surfactant proteins and anti-surfactant antibodies in sera from infants with respiratory distress syndrome with and without surfactant treatment. , 1991, Pediatrics.
[174] A. Jobe,et al. Surfactant treatments alter endogenous surfactant metabolism in rabbit lungs. , 1990, Journal of applied physiology.
[175] R. Barrow. Chemical structure of phospholipids in the lungs and airways of sheep. , 1990, Respiration physiology.
[176] J. Harkema,et al. Changes in lipids of lung lavage in monkeys after chronic exposure to ambient levels of ozone. , 1985, Toxicology letters.
[177] P. Richman,et al. Pulmonary surfactant suppresses the immune lung injury response to inhaled antigen in guinea pigs. , 1990, The Journal of laboratory and clinical medicine.
[178] H. Haagsman,et al. Synthesis and assembly of lung surfactant. , 1991, Annual review of physiology.
[179] P. Maasilta,et al. Changes in surfactant in bronchoalveolar lavage fluid after hemithorax irradiation in patients with mesothelioma. , 1990, The American review of respiratory disease.
[180] R. Matthay,et al. Drug-induced pulmonary disease. Part 1: Cytotoxic drugs. , 1986, The American review of respiratory disease.